MONTANOVA CAPITAL, LLC bought BNTC
March 26, 2025 · Form 4 insider transaction
MONTANOVA CAPITAL, LLC bought 793,800 shares of Benitec Biopharma Inc. at $13.00 per share, a transaction worth $10.32M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
793,800
Price
$13.00
Total value
$10.32M
InsiderMONTANOVA CAPITAL, LLC
RoleDirector, 10% owner
SecurityCommon stock, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateMarch 26, 2025
Filing dateMarch 28, 2025
Shares owned after8,793,245
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.